These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29751875)

  • 21. Management of recurrent hepatitis C virus after liver transplantation.
    Jiménez-Pérez M; González-Grande R; Rando-Muñoz FJ
    World J Gastroenterol; 2014 Nov; 20(44):16409-17. PubMed ID: 25469009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extrahepatic manifestations of HCV: the role of direct acting antivirals.
    Polo ML; Laufer N
    Expert Rev Anti Infect Ther; 2017 Aug; 15(8):737-746. PubMed ID: 28696154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic hepatitis C virus infection after liver transplantation.
    Agarwal K; Barnabas A
    Dig Liver Dis; 2013 Sep; 45 Suppl 5():S349-54. PubMed ID: 24091115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of hepatitis C infection before and after liver transplantation.
    Fagiuoli S; Ravasio R; Lucà MG; Baldan A; Pecere S; Vitale A; Pasulo L
    World J Gastroenterol; 2015 Apr; 21(15):4447-56. PubMed ID: 25914454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure.
    Colpitts CC; Baumert TF
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27537906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
    Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
    Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.
    Kim JH; Kim MN; Han KH; Kim SU
    Liver Int; 2015 Apr; 35(4):1103-15. PubMed ID: 24976523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of patients with chronic hepatitis C infection in Lombardia: a report by the Lombardia Hepatitis Network.
    Aghemo A; Bruno R; Colombo M; Medagli M; Puoti M; Rizzardini G; Fagiuoli S;
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(1 Suppl):17-19. PubMed ID: 28083863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence.
    Korda D; Lenard ZM; Gerlei Z; Jakab Z; Haboub-Sandil A; Wagner L; Varga M; Cseprekal O; Marton A; Horvathy D; Takacs S; Doros A; Mathe Z
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):27-32. PubMed ID: 29049126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real life experiences in HCV management in 2018.
    Viganò M; Andreoni M; Perno CF; Craxì A; Aghemo A; Alberti A; Andreone P; Babudieri S; Bonora S; Brunetto MR; Bruno R; Bruno S; Calvaruso V; Caporaso N; Cartabellotta F; Ceccherini-Silberstein F; Cento V; Ciancio A; Colombatto P; Coppola N; Di Marco V; Di Perri G; Fagiuoli S; Gaeta GB; Gasbarrini A; Lampertico P; Pellicelli A; Prestileo T; Puoti M; Raimondo G; Rizzardini G; Taliani G; Zignego AL
    Expert Rev Anti Infect Ther; 2019 Feb; 17(2):117-128. PubMed ID: 30582384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province.
    Kracht PAM; Arends JE; van Erpecum KJ; Thijsen SFT; Vlaminckx BJM; Weersink AJL; Wensing AMJ; Deege MPH; Dimmendaal M; Stadhouders PHGM; Friederich PW; Verhagen MAMT; Boland GJ; Hoepelman AIM
    Liver Int; 2019 Mar; 39(3):455-462. PubMed ID: 30204289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Hepatitis C Patients in the Direct-Acting Antiviral Era.
    Teriaky A; Reau N
    Clin Liver Dis; 2015 Nov; 19(4):591-604, v. PubMed ID: 26466649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus.
    Rupp C; Hippchen T; Neuberger M; Sauer P; Pfeiffenberger J; Stremmel W; Gotthardt DN; Mehrabi A; Weiss KH
    World J Gastroenterol; 2018 Mar; 24(12):1353-1360. PubMed ID: 29599610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
    Lin MV; Sise ME; Pavlakis M; Amundsen BM; Chute D; Rutherford AE; Chung RT; Curry MP; Hanifi JM; Gabardi S; Chandraker A; Heher EC; Elias N; Riella LV
    PLoS One; 2016; 11(7):e0158431. PubMed ID: 27415632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rethinking the reimbursement policy of direct acting antivirals against chronic hepatitis C].
    Girardin F; Goossens N; Vernaz N; Negro F
    Rev Med Suisse; 2015 Sep; 11(484):1610-2, 1614-6. PubMed ID: 26502622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece.
    Papadopoulos N; Manolakopoulos S; Deutsch M; Mela M; Christidou A; Katoglou A; Tzourmakliotis D; Papatheodoridis GV
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):587-93. PubMed ID: 23426269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.
    Durham DP; Skrip LA; Bruce RD; Vilarinho S; Elbasha EH; Galvani AP; Townsend JP
    Clin Infect Dis; 2016 Feb; 62(3):298-304. PubMed ID: 26628566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updates on hepatitis C virus therapy in the direct-acting antiviral era.
    Behara R; Reau N
    Curr Opin Gastroenterol; 2017 May; 33(3):115-119. PubMed ID: 28350558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Novel antiviral agents for the treatment of HCV among renal transplant recipients].
    Fabrizi F; Donato FM; Messa P
    G Ital Nefrol; 2017 Aug; 34(4):35-50. PubMed ID: 28762681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.